Publication:
A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model

Simple item page
dc.contributor.authorCenksoy, Cahit
dc.contributor.authorCenksoy, PINAR
dc.contributor.authorERDEM, OSMAN AYHAN
dc.contributor.authorSancak, Banu
dc.contributor.authorGursoy, Rifat
dc.contributor.institutionauthorÖZCAN, PINAR
dc.date.accessioned2020-12-16T20:59:17Z
dc.date.available2020-12-16T20:59:17Z
dc.date.issued2014-03-01T00:00:00Z
dc.description.abstractObjective: To investigate the effects of VIA receptor antagonist through inhibition of vasopressin-induced, VEGF secretion in an experimental model.
dc.identifier.citationCenksoy C., Cenksoy P., ERDEM O. A. , Sancak B., Gursoy R., -A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model-, EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.174, ss.86-90, 2014
dc.identifier.doi10.1016/j.ejogrb.2013.12.001
dc.identifier.scopus84894243189
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27706
dc.identifier.wosWOS:000333505500015
dc.titleA potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model
dc.typeArticle
dspace.entity.typePublication
local.avesis.id663ddce8-c88c-471b-8c29-dd60020efcb1
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublicationa223be34-acbb-4ec3-8217-209ec916f373
relation.isAuthorOfPublication.latestForDiscoverya223be34-acbb-4ec3-8217-209ec916f373

Files

Collections

Diğer Yayınlar